시장보고서
상품코드
1944487

심장 매핑 시장 : 종류별, 적응증별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Cardiac Mapping Market, By Type, By Indication, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 331 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심장 매핑 시장 규모는 2024년에 37억 8,912만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 7.5%로 확대될 전망입니다.

심장 매핑은 의사가 심장의 전기적 패턴을 추적하고 연구하여 부정맥을 식별하고 치료할 수 있는 첨단 전기생리학적 기법입니다. 이 과정에서 카테터 기반 전극을 심장에 삽입하고 전기 데이터를 수집하여 심장 내 비정상적인 전기적 임펄스 전파에 대한 상세한 지도를 생성합니다. 고급 심장 매핑 시스템은 2차원 및 3차원 전기 해부학 지도를 생성합니다. 이를 통해 의사는 부정맥을 유발하는 조직을 찾아내어 카테터 절제술을 정확하게 유도할 수 있어 시술의 효과와 환자의 치료 결과를 향상시킬 수 있습니다. 심장 매핑은 심방세동, 심방조동, 심실빈맥의 치료에서 표준적인 방법으로 작용하고 있으며, 현재 최소침습적 심장 전기생리학적 시술의 필수적인 요소로 자리 잡고 있습니다.

심장 매핑의 시장 역학

고령화와 심혈관질환(CVD)의 증가

심장 매핑 시장은 고령자 증가와 심혈관질환의 유병률 증가라는 두 가지 주요 요인으로 인해 확대되고 있습니다. 노화에 따른 심장의 구조적, 전기적 변화로 인해 노인은 심방세동, 심방조동, 심실빈맥 등의 부정맥이 발생하기 쉽습니다. 고혈압, 당뇨병, 비만, 운동 부족의 증가로 인해 전 세계적으로 심혈관질환의 위험 요인이 증가하고 있으며, 이에 따라 완벽한 진단 및 치료 솔루션을 필요로 하는 부정맥 환자가 증가하고 있습니다. 병원과 심장병원이 첨단 심장 매핑 기술을 통해 진단 능력, 치료 결과, 환자의 건강 상태를 개선하고자 하는 가운데, 특히 심장 매핑 시스템을 이용한 카테터 절제술을 포함한 전기생리학적 시술에 대한 수요가 증가하고 있습니다.

심장 매핑 시장 : 세분화 분석

종류별

2024년 현재, 접촉식 심장 매핑 시스템 부문이 가장 큰 시장 점유율을 차지하고 있습니다. 이러한 성장은 심장 이상 치료를 위해 입원하는 환자 수가 증가하면서 전 세계적으로 고급 심장 매핑 시스템에 대한 수요가 증가하고 있기 때문입니다. 주요 기업들이 자체 심장 매핑 시스템의 승인을 받기 위해 노력하고 있기 때문에 이 부문은 앞으로도 계속 확대될 것으로 예상됩니다.

심장 매핑 시장 - 지역별 분석

북미가 업계를 선도하고 있습니다. 미국과 캐나다는 높은 심장 박동 장애 발생률, 확립된 심장 치료 시설, 현대적 매핑 시스템의 완전한 도입, 주요 의료기기 제조업체의 존재로 인해 시장 지배력을 보여주고 있습니다. 치료 건수 증가, 지속적인 기술 발전, 전기생리학 개발에 대한 지속적인 자금 투입으로 북미는 향후 몇 년 동안 시장 리더의 지위를 유지하며 지역 및 세계 시장 전체에서 심장 매핑 시장의 상당한 성장을 주도할 것으로 예상됩니다.

목차

제1장 심장 매핑 시장 개요

제2장 주요 요약

제3장 심장 매핑의 주요 시장 동향

제4장 심장 매핑 시장 : 산업 분석

제5장 심장 매핑 시장 : 높아지는 지정학적 긴장의 영향

제6장 심장 매핑 시장 구도

제7장 심장 매핑 시장 : 종류별

제8장 심장 매핑 시장 : 적응증별

제9장 심장 매핑 시장 : 최종사용자별

제10장 심장 매핑 시장 : 지역별

제11장 주요 벤더 분석 : 심장 매핑 산업

제12장 AnalystView의 전방위적 분석

KSM

The Cardiac Mapping Market size was valued at US$3,789.12 Million in 2024, expanding at a CAGR of 7.5% from 2025 to 2032.

Cardiac mapping functions as an advanced electrophysiological method which enables doctors to track and study heart electrical patterns for the purpose of identifying and treating heart rhythm disorders. The process requires the insertion of catheter-based electrodes into the heart which they use to collect electrical data that produces detailed maps of abnormal electrical impulse propagation in the heart. Advanced cardiac mapping systems create two-dimensional and three-dimensional electro-anatomical maps which allow doctors to find arrhythmogenic tissue and direct catheter ablation treatments while enhancing their procedural effectiveness and patient results. Cardiac mapping functions as a standard method for treating atrial fibrillation and atrial flutter and ventricular tachycardia while serving as a vital component of current minimally invasive cardiac electrophysiology procedures.

Cardiac Mapping Market- Market Dynamics

Aging population and rising CVD burden

The cardiac mapping market experiences expansion because of two primary factors which include the increasing number of elderly people and the growing prevalence of cardiovascular diseases. The structural and electrical changes that occur in the heart because of aging make older adults more vulnerable to cardiac arrhythmias which include atrial fibrillation and atrial flutter and ventricular tachycardia. The global population experiences rising cardiovascular disease risk factors through increasing rates of hypertension and diabetes and obesity and lack of physical activity which results in more people developing rhythm disorders that need complete diagnostic and treatment solutions. The need for electrophysiology procedures is increasing especially for catheter ablation procedures which use cardiac mapping systems as hospitals and cardiac care centers seek to improve their diagnostic capabilities and procedure results and patient health through advanced cardiac mapping technologies.

Cardiac Mapping Market- Segmentation Analysis:

By Type

In 2024, the contact cardiac mapping systems segment holds the largest market share. The growth is due to increasing number of patient admissions for the treatment of heart abnormalities, which creates growing need for advanced cardiac mapping systems throughout the world. The segment will continue to expand because major companies now work to obtain approval for their cardiac mapping systems.

Cardiac Mapping Market- Geographical Insights

North America leads the industry. The United States and Canada exhibit market control because of their high occurrence of cardiac rhythm disorders and their established heart treatment facilities and their complete use of modern mapping systems and their presence of major medical equipment manufacturers. North America will keep its market leadership position through future years because of rising treatment numbers and continuous technological advancements and ongoing funding for electrophysiology development which will drive substantial growth in the cardiac mapping market throughout both regional and global markets.

Cardiac Mapping Market- Competitive Landscape:

The competitive landscape of the cardiac mapping market is led by a handful of large medtech firms that dominate through broad portfolios, global distribution, and heavy R&D investment-most notably Biosense Webster (Johnson & Johnson), Abbott, Boston Scientific, and Medtronic-while other established names (Philips, Siemens/GE partners, BIOTRONIK) and regional players (MicroPort, Lepu) fill out the field. The leading companies in the industry compete against each other by launching new mapping platforms and catheters which include 3D electro-anatomical systems and high-density/real-time mapping and integrated imaging and AI functionalities because these products create higher costs for customers who want to switch and they decrease the time products remain competitive in the market. A wave of smaller, fast-moving companies and startups (Acutus, Kardium, Biosig, Ablacon and others) develop niche advantages through their innovative sensor designs and signal-processing algorithms and affordable systems which drive established companies to develop new products and form partnerships and pursue targeted mergers and acquisitions.

Recent Developments:

In February 2025, Boston Scientific Corporation announced it has received CE mark for the navigation-enabled FARAWAVE(TM) NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) and for the new FARAVIEW(TM) Software. Both technologies will integrate and expand mapping option capabilities for cardiac ablation procedures using the FARAPULSE(TM) Pulsed Field Ablation (PFA) System, the most clinically proven PFA system for the treatment of AF, which has already benefited 200,000 patients globally. These technologies are compatible exclusively with the company's existing cardiac mapping technology and the company's latest offering, the OPAL HDx(TM) Mapping System.

In December 2025, Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt(TM) PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin commercial PFA cases in the United States and will continue its expansion of sites in the European Union following Volt CE Mark approval earlier this year.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC MAPPING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE HealthCare
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • EP Solutions SA
  • Acutus Medical
  • CathRx Ltd
  • Biosense Webster (Johnson & Johnson)
  • Siemens Healthineers
  • BIOTRONIK SE & Co. KG
  • Philips Healthcare
  • Lepu Medical Technology
  • Topera (Acquired by Abbott)
  • Stereotaxis Inc.
  • Bardy Diagnostics
  • CARTO (part of Biosense Webster)
  • Imricor Medical Systems
  • CardioFocus Inc.
  • APN Health, LLC

GLOBAL CARDIAC MAPPING MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Contact Cardiac Mapping Systems
  • Non-contact Cardiac Mapping Systems

GLOBAL CARDIAC MAPPING MARKET, BY INDICATION - MARKET ANALYSIS, 2019 - 2032

  • Atrial Fibrillation (AF)
  • Atrioventricular Reentrant Tachycardia (AVRT)
  • Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
  • Atrial Flutter
  • Ventricular Tachycardia (VT)
  • Premature Ventricular Contractions (PVCs)
  • Others

GLOBAL CARDIAC MAPPING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Specialty Clinics
  • Electrophysiology (EP) Labs
  • Hospitals and ASCs
  • Academic & Research Institutes
  • Others

GLOBAL CARDIAC MAPPING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cardiac Mapping Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cardiac Mapping Market Snippet by Type
    • 2.1.2. Cardiac Mapping Market Snippet by Indication
    • 2.1.3. Cardiac Mapping Market Snippet by End User
    • 2.1.4. Cardiac Mapping Market Snippet by Country
    • 2.1.5. Cardiac Mapping Market Snippet by Region
  • 2.2. Competitive Insights

3. Cardiac Mapping Key Market Trends

  • 3.1. Cardiac Mapping Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cardiac Mapping Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cardiac Mapping Market Opportunities
  • 3.4. Cardiac Mapping Market Future Trends

4. Cardiac Mapping Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cardiac Mapping Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cardiac Mapping Market Landscape

  • 6.1. Cardiac Mapping Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cardiac Mapping Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Contact Cardiac Mapping Systems
    • 7.1.3. Non-contact Cardiac Mapping Systems

8. Cardiac Mapping Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024&2032 (%)
    • 8.1.2. Atrial Fibrillation (AF)
    • 8.1.3. Atrioventricular Reentrant Tachycardia (AVRT)
    • 8.1.4. Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
    • 8.1.5. Atrial Flutter
    • 8.1.6. Ventricular Tachycardia (VT)
    • 8.1.7. Premature Ventricular Contractions (PVCs)
    • 8.1.8. Others

9. Cardiac Mapping Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 9.1.2. Specialty Clinics
    • 9.1.3. Electrophysiology (EP) Labs
    • 9.1.4. Hospitals and ASCs
    • 9.1.5. Academic & Research Institutes
    • 9.1.6. Others

10. Cardiac Mapping Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cardiac Mapping Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cardiac Mapping Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cardiac MappingKey Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cardiac Mapping Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cardiac MappingKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Cardiac Mapping Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. GE HealthCare
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Boston Scientific Corporation
    • 11.2.4. Medtronic plc
    • 11.2.5. MicroPort Scientific Corporation
    • 11.2.6. EP Solutions SA
    • 11.2.7. Acutus Medical
    • 11.2.8. CathRx Ltd
    • 11.2.9. Biosense Webster (Johnson & Johnson)
    • 11.2.10. Siemens Healthineers
    • 11.2.11. BIOTRONIK SE & Co. KG
    • 11.2.12. Philips Healthcare
    • 11.2.13. Lepu Medical Technology
    • 11.2.14. Topera (Acquired by Abbott)
    • 11.2.15. Stereotaxis Inc.
    • 11.2.16. Bardy Diagnostics
    • 11.2.17. CARTO (part of Biosense Webster)
    • 11.2.18. Imricor Medical Systems
    • 11.2.19. CardioFocus Inc.
    • 11.2.20. APN Health, LLC

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제